These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3071825)

  • 21. Effect of treatment with anti-IL-2-receptor monoclonal antibody and CsA on peripheral nerve allograft rejection.
    Grochowicz PM; Romaniuk A; Diamantstein T; Olszewski WL
    Transplant Proc; 1987 Oct; 19(5):4302-3. PubMed ID: 3118540
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preliminary report on preparation of monoclonal antibody against E receptor].
    Zhao YL; Xie SW; Liu EX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):73-5. PubMed ID: 6238705
    [No Abstract]   [Full Text] [Related]  

  • 24. Interleukin 2 receptors on an insulin-specific T cell line: dynamics of receptor expression.
    Reske-Kunz AB; von Steldern D; Rüde E; Osawa H; Diamantstein T
    J Immunol; 1984 Sep; 133(3):1356-61. PubMed ID: 6205080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody.
    Hand PH; Thor A; Schlom J; Rao CN; Liotta L
    Cancer Res; 1985 Jun; 45(6):2713-9. PubMed ID: 3157447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.
    Kelley VE; Gaulton GN; Hattori M; Ikegami H; Eisenbarth G; Strom TB
    J Immunol; 1988 Jan; 140(1):59-61. PubMed ID: 3121742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
    Palacios R
    J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
    Stingl LA; Sinska A; Landesmann U; Smolen JS
    Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody.
    Banerjee S; Wei BY; Hillman K; Luthra HS; David CS
    J Immunol; 1988 Aug; 141(4):1150-4. PubMed ID: 3135321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [General status and prospect of the use of monoclonal antibodies in endocrinology].
    Wu CY; Chi ZS
    Zhonghua Yi Xue Za Zhi; 1985 Dec; 65(12):758-62. PubMed ID: 3011228
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
    Reed JC; Greene WC; Hoover RG; Nowell PC
    J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression.
    Andrew ME; Churilla AM; Malek TR; Braciale VL; Braciale TJ
    J Immunol; 1985 Feb; 134(2):920-5. PubMed ID: 3917480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases.
    Guex-Crosier Y; Raber J; Chan CC; Kriete MS; Benichou J; Pilson RS; Kerwin JA; Waldmann TA; Hakimi J; Roberge FG
    J Immunol; 1997 Jan; 158(1):452-8. PubMed ID: 8977222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS; Calder VL; Feldmann M; Davison AN
    Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ; von Landenberg C; Barlage S; Schmitz G
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and characterization of monoclonal antibodies specific to IgE receptors on human lymphocytes by flow cytometry.
    Rector E; Nakajima T; Rocha C; Duncan D; Lestourgeon D; Mitchell RS; Fischer J; Sehon AH; Delespesse G
    Immunology; 1985 Jul; 55(3):481-8. PubMed ID: 3160655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the interleukin 2 receptor in differentiation of a clone of Ly-1+ B cells.
    Bishop GA; Haughton G
    J Immunol; 1987 May; 138(10):3308-13. PubMed ID: 3106480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.